Rick Bienkowski
Stock Analyst at Cantor Fitzgerald
(0)
# 4936
Out of 5,240 analysts
34
Total ratings
17.86%
Success rate
-32.42%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Legend Biotech | Reiterates: Overweight | 83 83 | 31.6 | 162.66% | 2 | Dec 9, 2024 | |
Beam Therapeutics | Upgrades: Outperform | 27 39 | 24.49 | 59.25% | 10 | Nov 6, 2024 | |
Arcellx | Initiates Coverage On: Overweight | n/a | n/a | n/a | 1 | Sep 3, 2024 | |
Intellia Therapeutic... | Reiterates: Overweight | 65 65 | 9.86 | 559.23% | 7 | Jun 24, 2024 | |
Caribou Biosciences | Initiates Coverage On: Neutral | n/a | n/a | n/a | 1 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 22 | 5.51 | 299.27% | 3 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 14 | 1.23 | 1038.21% | 6 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 112 107 | 39.72 | 169.39% | 4 | Aug 8, 2022 |